Mskcc Renal Cell Carcinoma Nomogram

In a randomized phase 3 trial sunitinib demonstrated superior efficacy over interferon alfa as first line therapy in patients with metastatic clear cell renal cell carcinoma.

Mskcc renal cell carcinoma nomogram.

2 3 objective response rates of 40 were observed with. If you are. Survival in patients with metastatic rcc mskcc. The prediction tools also known as prognostic nomograms located on the mskcc web site are for general health information only.

Our kidney cancer nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their surgical treatment for newly diagnosed renal cell carcinoma a type of kidney cancer. To get more information on renal cell carcinoma visit the web site of the american cancer society. The prediction tools are not to be used as a substitute for medical advice diagnosis or treatment of any health condition or problem. Breast additional non sln metastases.

Prognostic models recurrent advanced metastatic disease. Postoperative cancer specific survival following radical nephrectomy for clear cell renal cell carcinoma mayo ssign dssign 5. This health tool determines survival in the case of patient with metastatic renal cell carcinoma based on their clinical and laboratory data. Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma motzer 2008 cancer wiley online library.

This nomogram was designed to be used by physicians and people with renal cell carcinoma. It is based on the 670 patient original 1999 study by robert j motzer md at the memorial sloan kettering cancer center mskcc and is the most widely recognized prognostic algorithm for rcc. Postoperative 5 year recurrence free survival calculator for clear cell rcc 2005 mskcc nomogram 4. Ductal carcinoma in situ dcis recurrence.

Pfizer new york ny is a multitargeted tyrosine kinase inhibitor of vascular endothelial growth factor receptors and platelet derived growth factor receptors. The renal cell carcinoma tool consists of the motzer score resulted from the memorial sloan kettering cancer center mskcc study and the extended version created by mekhail. Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis. It is appropriate for patients who have undergone either radical nephrectomy complete surgical removal of a kidney or partial nephrectomy surgical removal of the cancerous.

1 its inhibitory profile provided the rationale for its study as an antiangiogenesis targeted therapy for clear cell renal cell carcinoma rcc.